[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [Praxis Precision Medicines, Inc. Common Stock](/topic/$prax) ### Price: $XXXXXX  [Price 24-Hour Time-Series Raw Data](/topic/$prax/time-series/close.tsv) The price action is likely due to the positive topline results from two pivotal Phase X studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor, as well as mentions in biotech catalyst watchlists. The stock hit a 52-week high of $XXX. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | XXXX% | XXX% | XXXXXX% | **1-Year High**: $XXX on 2025-10-17 **1-Year Low**: $XXXXX on 2025-04-10
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Praxis Precision Medicines, Inc. Common Stock
Price: $XXXXXX
Price 24-Hour Time-Series Raw Data
The price action is likely due to the positive topline results from two pivotal Phase X studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor, as well as mentions in biotech catalyst watchlists. The stock hit a 52-week high of $XXX.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | XXX% | XXXXXX% |
1-Year High: $XXX on 2025-10-17
1-Year Low: $XXXXX on 2025-04-10